study, including what was actually discussed between patients and their oncologists, and whether patients simply misunderstood or misheard the information conveyed to them,” El-Jawahri said in a meeting news release.
Still, the urgency of decision-making required with AML may contribute to differences in perception, the researchers said. Previous work with patients treated for other types of cancer didn’t uncover such pronounced distortions.
For more information on acute myeloid leukemia, visit our Health Conditions page on BlackDoctor.org.
SOURCE: American Society of Clinical Oncology, news release, Oct. 23, 2017